In breast cancer cells, NCOR2 was proposed as a candidate to initiate cancer cell growth by modifying the transcriptional activity of ERα or directly influencing the ERα expression (Ciriello et al. 2013; Dobrzycka 2003; Kurebayashi et al. 2000). This evidence concerns the gene ESR1 and breast cancer.